Laurent Arnaud

2000–2025 年に発表

185
論文数
18,144
被引用数
80
h 指数
165
i10 指数

被引用数

Laurent Arnaud の年別被引用数1978 年: 被引用 2 件2000 年: 被引用 1 件2003 年: 被引用 1 件2005 年: 被引用 1 件2006 年: 被引用 7 件2007 年: 被引用 2 件2008 年: 被引用 5 件2009 年: 被引用 10 件2010 年: 被引用 17 件2011 年: 被引用 40 件2012 年: 被引用 42 件2013 年: 被引用 80 件2014 年: 被引用 156 件2015 年: 被引用 170 件2016 年: 被引用 106 件2017 年: 被引用 156 件2018 年: 被引用 105 件2019 年: 被引用 398 件2020 年: 被引用 521 件2021 年: 被引用 581 件2022 年: 被引用 591 件2023 年: 被引用 375 件2024 年: 被引用 866 件2025 年: 被引用 509 件2026 年: 被引用 18 件1979〜1999 年は被引用が無いため表示していません2001〜2002 年は被引用が無いため表示していません2004 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,158 件、この内訳の 16.4%フランス: 引用元論文 618 件、この内訳の 8.7%中国: 引用元論文 547 件、この内訳の 7.7%イタリア: 引用元論文 494 件、この内訳の 7%イギリス: 引用元論文 462 件、この内訳の 6.5%ドイツ: 引用元論文 343 件、この内訳の 4.8%スペイン: 引用元論文 235 件、この内訳の 3.3%カナダ: 引用元論文 230 件、この内訳の 3.3%オランダ: 引用元論文 209 件、この内訳の 3%日本: 引用元論文 197 件、この内訳の 2.8%オーストラリア: 引用元論文 171 件、この内訳の 2.4%スウェーデン: 引用元論文 170 件、この内訳の 2.4%
0%16.4%その他 31.7%

分野

  • Medicine76.8%
  • Biochemistry, Genetics and Molecular Biology9.6%
  • Immunology and Microbiology4.7%
  • Earth and Planetary Sciences2.8%
  • Engineering1.8%
  • Materials Science0.9%
  • その他3.4%

トピック

  • Systemic Lupus Erythematosus Research10.1%
  • Rheumatoid Arthritis Research and Therapies3.6%
  • Systemic Sclerosis and Related Diseases2.5%
  • Histiocytic Disorders and Treatments2.3%
  • T-cell and B-cell Immunology2.2%
  • Extracellular vesicles in disease2.1%
  • その他77.2%

共著者

全論文

検索で開く
  1. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Yoshiya Tanaka, Maria G. Tektonidou, Y K Onno Teng, Anǵela Tincani, Edward M Vital, Ronald van Vollenhoven, Chris Wincup, George Βertsias, Dimitrios T. Boumpas - Annals of the Rheumatic Diseases 2023 被引用: 933

  2. 2021 DORIS definition of remission in SLE: final recommendations from an international task force

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raquel Faria, Rebecca S. B. Fischer, Ruth Fritsch‐Stork, Murat İnanç, Søren Jacobsen, David Jayne, Annegret Kuhn, Bernadette van Leeuw, Maarten Limper, Xavier Mariette, Sandra Navarra, Mandana Nikpour, Marzena Olesińska, Guillermo Pons‐Estel, Juanita Romero‐Díaz, Blanca Rubio, Y Schoenfeld, Eloísa Bonfá, Josef S Smolen, Y K Onno Teng, Anǵela Tincani, Michel Tsang-A-Sjoe, Carlos Vasconcelos, Anne Voss, Victoria P. Werth, Elena Zakharhova, Cynthia Aranow - Lupus Science & Medicine 2021 被引用: 349

  3. Systemic lupus erythematosus

    著者: , , , - The Lancet 2024 被引用: 327

  4. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge

    著者: , , , , - Therapeutic Advances in Musculoskeletal Disease 2022 被引用: 194

  5. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Véronique Le Guern, Kirsten Lerstrøm, Roger A. Levy, Francinne Machado-Ribeiro, Xavier Mariette, Jamil Missaykeh, Eric F. Morand, Marta Mosca, Murat İnanç, Sandra Navarra, Irmgard Neumann, Marzena Olesińska, Michelle Petri, Anisur Rahman, Ole Petter Rekvig, Jozef Rovenský, Yehuda Shoenfeld, Josef S Smolen, Anǵela Tincani, Murray B. Urowitz, Bernadette van Leeuw, Carlos Vasconcelos, Anne Voss, Victoria P. Werth, Elena Zakharova, Asad Zoma, Matthias Schneider, Michael M. Ward - Annals of the Rheumatic Diseases 2016 被引用: 357

  6. The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database

    著者: , , , , , - Annals of the Rheumatic Diseases 2019 被引用: 369

  7. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 被引用: 225

  8. Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

    著者: , , , , , , , , , , , , , , , , , , - Autoimmunity Reviews 2020 被引用: 153

  9. EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2023 被引用: 120

  10. Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors

    著者: , - Lara D. Veeken 2020 被引用: 176

  11. Immunopathogenesis of systemic lupus erythematosus: An update

    著者: , , - Autoimmunity Reviews 2024 被引用: 89

  12. Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , François Lifermann, Maxime Samson, Susann Pechuzal, Achille Aouba, Olivier Kosmider, Jérémie Dion, S. Grosleron, R. Bourguiba, Benjamin Terrier, Sophie Georgin‐Lavialle, O. Fain, A. Mékinian, Marjolaine Morgand, Thibault Comont, Jérôme Hadjadj, Isabelle Melki, Pierre Fenaux, Lionel Adès, A. Audemard, Mikaël Ebbo, Yvan Jamilloux, Odile Beyne Rauzy, Alexandre Bélot, Raphaël Borie, Alexis Mathian, Laurent Arnaud, François Chasset, Jean‐David Bouaziz, Pierre Sujobert, Y. Benhamou, Gaëtan Sauvêtre, Khalil El-Karoui, François Rodrigues - Annals of the Rheumatic Diseases 2023 被引用: 71

  13. Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19

    著者: , , , , , , , , , , , , , , , - Blood Advances 2021 被引用: 150

  14. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

    著者: , , , , , , , , , , , , , , , , , , , , , , - Blood 2012 被引用: 693

  15. Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway

    著者: , , , , , , , , , , , , , , - Kidney International 2013 被引用: 237

  16. The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand?

    著者: , - Journal of Clinical Medicine 2021 被引用: 92

  17. Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: An international and collaborative meta-analysis

    著者: , , , , , , , , , , , , , - Autoimmunity Reviews 2013 被引用: 215

  18. Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George Βertsias, Ilaria Bini, Anca Bobîrcă, Ware Branch, Antonio Brucato, Irene E. M. Bultink, S. Capela, Irene Cecchi, Ricard Cervera, Cecilia Beatrice Chighizola, Claudia Cobilinschi, María José Cuadrado, Dzifa Dey, Oseme Etomi, Gerard Espinosa, Julia Flint, João-Eurico Fonseca, Ruth Fritsch‐Stork, Maria Gerosa, Bente Glintborg, Carina Gøtestam Skorpen, Bethan Goulden, Christine Graversgaard, Iva Gunnarsson, Latika Gupta, Merete Lund Hetland, Kenneth Hodson, Beverley J. Hunt, David Isenberg, Søren Jacobsen, Munther A. Khamashta, Roger A. Levy, Louise Linde, Jacob Alexander Lykke, Yvette Meißner, Louise Moore, Eric F. Morand, Sandra Navarra, Daniela Opriș-Belinski, Monika Østensen, Hiroki Ozawa, Luis Fernando Pérez-García, Michelle Petri, Guillermo Pons‐Estel, Massimo Radin, Luigi Raio, Amihai Rottenstreich, Guillermo Ruiz‐Irastorza, Slađana Rumpl Tunjić, Marite Rygg, Savino Sciascia, Anja Strangfeld, Elisabet Svenungsson, Maria G. Tektonidou, Anne Troldborg, Évelyne Vinet, Jelena Vojinović, Anne Voss, Marianne Wallenius, Laura Andréoli - The Lancet Rheumatology 2023 被引用: 34

  19. Living with systemic lupus erythematosus in 2020: a European patient survey

    著者: , , , , - Lupus Science & Medicine 2021 被引用: 88

  20. Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , B. Faucher, Jean‐David Bouaziz, Jonathan Broner, Cyril Dumain, Carole Antoine, Benjamin Carpentier, Brice Castel, Céline Lartigau-Roussin, Étienne Crickx, Geoffroy Volle, Damien Fayard, Paul Decker, T. Moulinet, Anaël Dumont, Alexandre Nguyen, Achille Aouba, Jean-Philippe Martellosio, M. Levavasseur, S. Puigrenier, Pascale Antoine, Jean-Thomas Giraud, Olivier Hermine, Carole Lacout, Nihal Martis, J.D. Karam, François Chasset, Laurent Arnaud, Paola Marianetti, C. Deligny, Thibaud Chazal, Pascal Woaye-Hune, Murielle Roux-Sauvat, A. Meyer, Pierre Sujobert, Pierre Hirsch, Noémie Abisror, Pierre Fenaux, Olivier Kosmider, Vincent Jachiet, O. Fain, Benjamin Terrier, A. Mékinian, Sophie Georgin‐Lavialle, Sophie Georgin-Lavialle, Isabelle Melki, Lionel Adès, Lin‐Pierre Zhao, A. Audemard, Mikaël Ebbo, Odile Beyne Rauzy, Alexandre Bélot, Raphaël Borie, Y. Benhamou, Gaëtan Sauvêtre, Khalil El Karoui, François Rodrigues, Louis Terriou, Jérémie Dion - Annals of the Rheumatic Diseases 2024 被引用: 64

  21. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease

    著者: , , , , , , , , , , , , , , , , - Blood 2014 被引用: 586

  22. Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine Peschken, Bernardo A. Pons‐Estel, Anisur Rahman, Rosalind Ramsey‐Goldman, John A. Reynolds, Juanita Romero‐Díaz, Guillermo Ruiz‐Irastorza, Jorge Sánchez‐Guerrero, Elisabet Svenungsson, Murray B. Urowitz, Évelyne Vinet, Ronald van Vollenhoven, Alexandre E. Voskuyl, Daniel J. Wallace, Michelle Petri, Susan Manzi, Ann E. Clarke, Mike W.‐L. Cheung, Vernon T. Farewell, Graciela S. Alarcón - Lupus Science & Medicine 2021 被引用: 91

  23. Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus

    著者: , , , , , , , , , , , - Autoimmunity Reviews 2017 被引用: 107

  24. 10 most important contemporary challenges in the management of SLE

    著者: , , , , , , , , , , , , - Lupus Science & Medicine 2019 被引用: 78